drugset
drugset / Trial / NCT05353010

A Study to Evaluate Effect of IN-A001 on Pharmacokinetics of Tacrolimus in Healthy Volunteers

NCT05353010 ↗

Phase 1 Unknown 12 enrolled HK inno.N Corporation
NaSequentialOpen-labelTreatment

Summary

This study aims to investigate the effect of IN-A001 50mg on the pharmacokinetics of Tacrolimus 5mg in healthy volunteers

Timeline

Start
2022-05-01
Primary completion
2022-07-01
Completion
2022-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule 5 mg Oral
Subject Tegoprazan Other / unclassified 50 mg Oral

Indications

No indication recorded.